The mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK), and p38 MAP kinase (p38) signaling cascades are involved in triggering apoptosis in somatic cells. Given that spermatozoa are able to undergo apoptosis, we tested the hypothesis that these pathways might be functional in ram spermatozoa as two signal transduction mechanisms that contribute to the modulation of capacitation and apoptosis. Indirect immunofluorescence and western blot analysis evidenced the presence of JNK and p38 in ram spermatozoa. To verify the involvement of these enzymes in sperm physiology, we determined the effect of specific inhibitors of JNK or p38 on in vitro capacitation induced with either cAMP-elevating agents or epidermal growth factor (EGF). Both inhibitions reduced the EGF-induced capacitation with a decrease in the chlortetracycline capacitated-sperm pattern, protein tyrosine phosphorylation, phosphatidylserine externalization, caspase-3 and -7 activation, and the proportion of DNA-damaged spermatozoa. No significant changes were found in the high-cAMP capacitated samples. The addition of 3.4 mg/ml seminal plasma proteins (SPPs) to the EGF-containing samples, either alone or together with each inhibitor, resulted in a decreased proportion of capacitated sperm pattern, protein tyrosine phosphorylation, loss of plasma membrane integrity, and apoptotic alterations. Furthermore, SPPs significantly reduced the phosphorylation level of JNK and p38 MAPK (active forms). These findings show a relationship between capacitation and apoptosis, and represent a step forward in the knowledge of the SPP protective mechanism in spermatozoa.
Introduction
Mitogen-activated protein kinases (MAPKs) are regulatory enzymes involved in a large variety of cell functions including growth, differentiation, survival, proliferation, migration, stress, and apoptosis [1] [2] [3] [4] . Mammalian cells contain the well-characterized ERK pathway and two MAPKs, the c-Jun N-terminal kinase (JNK), and the p38 MAPK [1, 5] , whose activation is also mediated by protein kinase cascades parallel to that responsible for ERK activation, which generally leads to inflammation and apoptosis [6] .
Isoforms of ERK, JNK, and p38 have been described in both Sertoli and germ cells in the seminiferous epithelium [7] , and it has been shown that they have a functional role in spermatogenesis [8] . The ERK module is involved in the capacitation of human [9] , mouse [10] , boar [11] , and ram [12] spermatozoa. MAPK regulation is also needed for spermatozoa to acquire motility during the epididymal transit and for oocyte fertilization (see [13] for review). Several studies have also shown possible correlations between MAPK pathways and sperm quality parameters [5, 6, 9, 14, 15] .
It has long been known that ejaculated spermatozoa acquire progressively their ability to fertilize the oocyte throughout their journey in the female reproductive tract (capacitated; [16, 17] ) or in vitro with media that mimic the oviductal fluid [18] . Although ram spermatozoa are difficult to capacitate in vitro, the involvement of the canonical cAMP-dependent protein kinase A (PKA) in regulating the tyrosine phosphorylation events associated with capacitation has been well established [19] . More recently, we have also reported the significance of a new alternative pathway including the MAPK ERK1/2 signaling cascade activated by epidermal growth factor and its receptor (EGF/EGFR) [12] . In addition, we have already proved that ram sperm capacitation seems to share molecular signaling pathways with apoptosis, and that seminal plasma proteins (SPPs) are able to protect ram spermatozoa by preventing the apoptotic-associated events [20] , which could be related to the SPP decapacitating role [21] .
Therefore, gaining an accurate and deep understanding of the possible relationship between capacitation and apoptosis is of great importance for the improvement of reproductive biotechnologies. Given that the MAPK, JNK, and p38 signaling cascades are involved in triggering apoptosis in somatic cells [22] [23] [24] [25] , and that spermatozoa are able to undergo apoptosis through an extrinsic or intrinsic mechanism [20, 26] , we may hypothesize that these pathways can be functional in ram spermatozoa as two signal transduction mechanisms that contribute to the modulation of capacitation and apoptosis. Therefore, in this study we examined the presence of both JNK and p38 MAPKs in ram spermatozoa as well as their activation state during in vitro capacitation with EGF. To verify the involvement of the JNK and p38 pathways in sperm physiology, we tested the effect of specific JNK and p38 inhibitors, inducing capacitation with either cAMP-elevating agents or EGF. Another important unresolved issue is the role that SPP plays in both capacitation and apoptosis, and the identification of molecular signaling cascades that both processes might share. Our results show a relationship between capacitation and apoptosis, and that SPPs can protect spermatozoa by hampering these processes.
Materials and methods

Semen collection and processing
All the experiments were carried out with fresh semen obtained from eight mature Rasa Aragonesa rams (2-4 yr old) using an artificial vagina. All the rams belonged to the National Association of Rasa Aragonesa Sheep Breeders (ANGRA) and were housed under uniform nutritional conditions at the Experimental Farm of the University of Zaragoza in compliance with the requirements of the European Union Directive for Scientific Procedures. The sires were kept apart, semen was collected every 2 days, in two successive matings each day. Semen obtaining and use were performed in accordance with the ethical guidelines for care and use of agricultural animals for research, under Project License PI34/11 approved by the Ethic Committee for Animal Research of the University of Zaragoza. Under these conditions, and using second ejaculates, individual differences are very low, as we have already reported [27] , and pooled ejaculates provide a good quality, uniform sperm sample suitable for representative studies of ram semen. Sperm concentration was calculated in duplicate using Neubauer's chamber (Marienfeld, LaudaKönigshofen).
A seminal plasma (SP)-free sperm population was obtained by a dextran/swim-up procedure [28] performed by using a swim-up medium consisting of 200 mM sucrose, 50 mM NaCl, 18.6 mM sodium lactate, 21 mM HEPES, 10 mM KCl, 2.8 mM glucose, 0.4 mM MgSO 4 , 0.3 mM sodium pyruvate, 0.3 mM K 2 HPO 4 , 5 mg/ml of BSA 1.5 IU/ml penicillin, and 1.5 mg/ml streptomycin, pH 7.2 (adjusted by NaOH addition), and devoid of CaCl 2 and NaHCO 3 [29] .
Seminal plasma protein preparation
Seminal plasma was obtained by spinning 1 ml of semen at 12 000 × g for 5 min at 4
• C. The supernatant was centrifuged again, and 400
μl of undiluted SP were taken and, after filtering through a 0.22-μm membrane, kept at -20
Whole SPPs were obtained [30] by filtering the SP through Microsep microconcentrators (Filtron Tech, Northborough, MA, USA) of a 3-kDa molecular weight cut-off, spinning for 6 h at 3000 × g at 4
• C. The obtained sample was diluted with five volumes of a medium containing 0.25 M sucrose, 0.1 mM EGTA, 4 mM sodium phosphate (pH 7.5), 10% (v/v) of 10 × buffer stock HEPES (50 mM glucose, 100 mM HEPES, 20 mM KOH) and then centrifuged again; SPPs were recovered and aliquots were stored at -20
• C until use. Protein concentration was assessed using the bicinchoninic acid (BCA) cooper reagent [31] (Pierce BCA Protein Assay Kit, Thermo Fisher Scientific, Waltham, MA, USA).
In vitro capacitation and sperm sample treatments
Aliquots of 1.6 × 10 8 cells/ml freed from SPP by swim-up were incubated for 3 h at 39
• C in a humidified incubator with 5% CO 2 in air. Incubations were performed in complete TALP medium [32] containing 100 mM NaCl, 3.1 mM KCl, 25 mM NaHCO 3 , 0.3 mM NaH 2 PO 4 , 21.6 mM Na lactate, 3 mM CaCl 2 , 0.4 mM MgCl 2 , 10 mM HEPES, 1 mM Na pyruvate, 5 mM glucose, and 5 mg/ml bovine serum albumin (BSA), pH 7.2 (adjusted using NaOH). This sample was used as control of capacitation. The compounds described below were added to this medium at the same time as the rest of components immediately after preparing the aliquots (0 h).
To confirm the involvement of JNK and p38 MAPKs in in vitro capacitation, we induced capacitation under two different conditions: (1) a high-cAMP medium (cocktail, cAMP-PKA pathway), already proved for capacitating ram spermatozoa [19, 29] composed of dibutyryl-cAMP (Sigma Chemical Co., Madrid, Spain; 1 mM), caffeine and theophylline (both inhibitors of phosphodiesterases, Sigma Chemical Co., Madrid, Spain; 1 mM each), okadaic acid (a broad spectrum phosphatase inhibitor, Sigma Chemical Co., Madrid, Spain; 0.2 μm), and methyl-β-cyclodextrin (Sigma Chemical Co., Madrid, Spain; 2.5 mM); 2) adding 100 nM EGF (Abcam, Cambridge, UK) to the TALP-BSA medium (EGF-capacitated samples) previously proved as an inductor of ram sperm capacitation [12] .
To study the inhibition of both JNK and p38 stress-activated MAPKs, we tested the effect of two specifically selective inhibitors. The JNK (SP 600125, JNKi) and p38 (SB 203580, p38i) inhibitors (both purchased from Sigma-Aldrich, St. Louis, MO, USA) were individually added to control, high-cAMP, and EGF-containing groups of treatment. First, we assayed different concentrations (50, 70 , and 100 μM) of each inhibitor, within the range suggested in the reviewed literature [33] [34] [35] [36] . Due to the most significant effect was obtained at a concentration of 100 μM SP 600125 or SB 203580, this was the selected dose for the next experiments.
Finally, in order to examine the mechanism by which SPPs could exert their effect on capacitation and apoptosis [20, 21] , we added 3.4 mg/ml of SPP [20] to 500 μl of EGF-capacitated samples (8 × 10 7 spermatozoa in 500 μl). SPPs were thawed at room temperature (RT) and immediately added after preparing the capacitation aliquots (0 h), which were then incubated for 3 h simultaneously with the controls Two control samples (with no SPP) corresponding to the control of capacitation in basal medium (BSA+TALP) and the control of EGF-containing sample were included in all assays and incubated for 3 h in capacitating conditions.
Indirect immunofluorescence assays
The localization of JNK and p38 MAPKs was investigated by indirect immunofluorescence analysis as previously reported [12] . Sperm samples were diluted (4 × 10 6 cells/ml) in phosphate-buffered saline (PBS, pH 7.2) and fixed in suspension for 20 min in 0.025% paraformaldehyde. After fixation and washing, the cell samples that were processed in triplicate were allowed to settle on Superfrost slides (Superfrost Plus, Thermo Fisher Scientific; Waltham, MA, USA) and permeabilized with 0.5% Triton X-100 in PBS for 15 min. A second fixation was carried out for 5 min in 1.25% paraformaldehyde. The slides were then washed three times with PBS, and nonspecific binding sites were blocked with 5% BSA in PBS overnight at 4
• C in a wet chamber. After blocking, the slides were again washed three times with PBS and the corresponding antibody was added.
The primary antibodies used in this study were rabbit polyclonal anti-JNK/SAPK1 (Millipore; Merck Millipore, Darmstadt, Germany) and rabbit polyclonal anti-p38 (Sigma-Aldrich, St. Louis, MO, USA), 1/20 in PBS with 1% BSA. In accordance with the manufacturer´s information, both rabbit antibodies were predicted to cross-react with many other species, including ovine, based on 100% sequence homology with the immunogen. The preparations were incubated overnight at 4
• C in a wet chamber, washed three times, Sperm cells incubated without either the primary or the secondary antibodies were used as negative controls (data not shown). Images were obtained using a microscope digital camera system (Sony 2CCD Color Video Camera and Sony Digital Still Recorder), and saved and edited with NIS-Elements Software (Nikon, Tokyo, Japan).
Extraction of sperm proteins
Aliquots of 3.2 × 10 7 spermatozoa of control, cAMP, or EGFcapacitated samples were resuspended in 100 μl of the same extraction medium previously used [19] composed of 2% SDS (w/v), 0.0626 mM TRIS-HCl (pH 6.8), 0.002% bromophenol blue in 10 % glycerol (final glycerol concentration 1%), and protease and phosphatase inhibitors (Sigma Chemical Co., Madrid, Spain), and immediately incubated for 5 min at 100 • C. After centrifugation at 7500 × g for 5 min at RT, the supernatant was recovered, and 2-mercaptoethanol and glycerol were added to a final concentration of 5% and 1%, respectively. Lysates were stored at -20
Protein concentration was determined using the BCA assay [31] .
SDS-PAGE and immunoblotting
Sperm extracted proteins (20 μg, extracted from 6.4 × 10 6 spermatozoa) were separated in one dimension on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) following the Laemmli method [37] , using a mini protean II vertical slab gel electrophoresis apparatus (Bio-Rad, Hercules, CA, USA). Electrophoresis was performed for 1 h and 30 min at 130 V at 4
• C. A mixture of prestained molecular weights ranging from 10 to 250 kDa (Bio-Rad, Hercules, CA, USA) was used as a standard. Separated proteins were blotted onto 0.2 μm polyvinylidene fluoride membranes (Bio-Rad, Hercules, CA, USA) at 2.5 A constant up to 25 V, 10 min, using the Trans-Blot Turbo unit (Trans-Blot TurboTM Transfer System, Bio-Rad, Hercules, CA, USA).
To identify both JNK and p38 MAPKs and their activated (phosphorylated) forms, nonspecific binding sites on membranes were blocked for 1 h with 5% BSA (w/v) in PBS (136 mM NaCl, 0.2 g/l KCl, 1.44 g/l Na 2 HPO 4 , and 0.24 g/l KH 2 PO 4 , pH 7.4). Primary antibodies, anti-JNK/SAPK1, anti-phospho-JNK (Thr1983/Tyr185, Thr221/Tyr223), and anti-phospho-p38α (Thr180/Tyr182) purchased from Millipore (Millipore, Temecula, CA, USA) and anti-p38 from Sigma-Aldrich (Sigma Chemical Co., Madrid, Spain), all produced in rabbit, were diluted 1/1000 in 1% BSA (w/v) in PBS and incubations were performed overnight at 4
• C, followed by one further hour at RT with the secondary anti-rabbit horseradish peroxidase (HRP)-linked antibody (GE HealthcareAmersham, Little Chalfont, UK), diluted 1/20 000 with 1% BSA (w/v) in PBS. After primary and secondary antibody incubations, extensive washes were carried out to eliminate unspecific binding. The proteins that bound the antibody were visualized by chemiluminescence procedures (Pierce ECL Western Blotting Substrate; Thermo Fisher Scientific, Waltham, MA, USA). A positive antigen control consisted of 10 μg of an EGF-stimulated A431 cell lysate (Millipore; Merck Millipore, Darmstadt, Germany) was used. For detection of phosphorylated proteins, the blots were incubated as previously described [12] . Nonspecific sites on the membranes were blocked for 1 h with 5% BSA (w/v) in PBS at RT. Then, the blots were incubated with the mouse monoclonal antiphosphotyrosine antibody (Monoclonal Antibody, clone 4G10, Millipore, Temecula, CA, USA), diluted 1/1000, overnight at 4
• C, followed by incubation for 1 h at RT with a secondary anti-mouse HRPconjugated IgG antibody (1/40 000; GE Healthcare-Amersham, Little Chalfont, UK). Anti-actin antibody (Sigma Chemical, A2066) produced in rabbit was used as a loading control. Blots previously probed with the anti-phosphotyrosine antibody were stripped by incubation of the membranes in restore stripping buffer (100 mM β-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl pH 6.7) for 45 min at 50
• C with constant agitation. After extensive washing with 0.1%
Tween-20 PBS (PBST), blots were blocked again by immersing the membranes in 5% BSA and PBS for 1 h, and reprobed with the rabbit anti-actin antibody diluted 1:1000 (v/v) in 1% BSA and PBST, followed by incubation with a secondary donkey anti-rabbit IRDye 680-CW antibody diluted 1:15000 (v/v). Other controls omitting either the primary or the secondary antibodies were also carried out (data not shown). After extensive washing, the proteins that bound the antibody were visualized by chemiluminescence procedures as described above. Western blot images were quantified using Quantity One software (Bio-Rad, Hercules, CA, USA). In order to better compare differences in intensity of the tyrosine-phosphorylated protein bands, densitometric quantification was carried out without including the most intense bands (45 and 77-98 kD region). The signal intensity of each lane was normalized to the actin loading control. To avoid the high differences due to the western development of each individual experiment, the corresponding controls (at 0 and 3 h) were always included in each blot. Each experiment was performed four times, and presented data are means ± SEM of relative intensity units.
Determination of capacitation status
The capacitation status was determined by means of the chlortetracycline (CTC) fluorescence assay that we previously validated for the evaluation of capacitation and acrosome reaction-like changes in ram semen [29] . Three sperm types were estimated [38] : noncapacitated (NC, even distribution of fluorescence on the head, with or without a bright equatorial band), capacitated (C, with fluorescence in the anterior portion of the head), and acrosome-reacted cells (AR, showing no fluorescence on the head).
We examined the samples, within 12 h, using a Nikon Eclipse E-400 microscope under epifluorescence illumination with a V-2A filter. All samples were processed in duplicate, and at least 200 spermatozoa were scored per slide. No fluorescence was observed when CTC was omitted from the preparation.
Flow cytometry analysis
All the measurements were performed on a Beckman Coulter FC 500 (IZASA, Barcelona, Spain) with CXP software, equipped with two lasers of excitation (argon ion laser 488 nm and solid state laser 633 nm) and five filters of absorbance (FL1-525, FL2-575, FL3-610, FL4-675, and FL5-755; ± 5 nm each band pass filter). At a minimum, 20 000 events were counted in all the experiments. The sperm population was gated for further analysis on the basis of its specific forward (FS) and side scatter (SS) properties; other nonsperm events were excluded. A flow rate stabilized at 200-300 cells per second was used.
To determine cell viability (membrane integrity), 3 μl of each stain, carboxyfluorescein diacetate (CFDA; 1 mM; Sigma Chemical Co., Madrid, Spain), propidium iodide (PI; 0.75 mM; Sigma Chemical Co., Madrid, Spain), and 37% formaldehyde were added to 400 μl of sperm samples (final concentration of 8 × 10 6 cell/ml), based on a modification of the procedure described by Harrison and Vickers [39] . Samples were incubated at 37
• C in darkness for 15
min. The argon laser and filters of 525 and 675 nm were used to avoid overlapping. Monitored parameters were FS log, SS log, FL1 (CFDA), and FL4 (PI). Phosphatidylserine (PS) translocation was assessed by Annexin V-FITC/PI staining. Annexin V is a calcium-dependent phospholipidbinding protein with high affinity for PS [40] [41] [42] . We used the simultaneous staining with FITC-Annexin V (Molecular Probes, Thermo Fisher Scientific, Waltham, MA, USA) to detect PS translocation along with PI to differentiate between membrane-intact and damaged cells, with or without PS translocation [43] . Aliquots of 300 μl (6 × 10 6 cells) were stained with FITC-Annexin V (1 μl) combined with 7.5 μM PI and incubated at 37 To detect active caspase-3 and -7, the caspase FITC-VAD-FMK In Situ marker (Vybrant FAM Caspase-3 and -7 Assay Kit; Invitrogen, Eugene, OR, USA) was used [44] . Samples of 300 μl (6 × 10 6 cells) containing FITC-VAD-FMK (5 nM) were incubated at 37
• C and 5% CO 2 in the dark for 60 min. After washing twice with 100 μl of washing buffer (supplied with the kit) by centrifuging at 600 × g for 8 min at RT, the obtained pellet was resuspended with 300 μl of washing buffer containing 7.3 μM ethidium homodimer (Eth), and flow cytometry was performed within 10 min. Monitored parameters were FS log, SS log, FL1 (FITC-VAD-FMK), and FL4 (Eth). With this technique, four sperm subpopulations were distinguished: events in the lower quadrants represented intact spermatozoa, nonapoptotic (left quadrant, FITC-VAD−/Eth−) or with active caspase-3 and -7 (right quadrant, FITC-VAD+/Eth−); events in the upper quadrants represented dead spermatozoa, with (right, FITC-VAD+/Eth+) or without (left, FITC-VAD−/Eth+) active caspases. The presence of apoptosis-like DNA-strand breaks was evaluated by the TUNEL (terminal transferase-mediated dUDP nick end-labeling) assay using an In Situ Cell Death Detection Kit with fluorescein isothiocyanate (FITC)-labeled dUTP (Roche, Mannheim, Germany) [45] . Sperm samples (4 × 10 7 cells/ml) were fixed with 4% paraformaldehyde in PBS at RT for 1 h. After two washes with 200 μl of PBS, the samples were permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate for 2 min at 4
• C. The elongation reaction was performed by incubating the obtained pellet with 50 μl of labeling solution that contained the TdT enzyme and dUTP for 1 h at 37
• C in the dark. For each experimental set, a negative control was prepared by omitting TdT from the reaction mixture. Two subsequent washes with PBS at 600 × g for 10 min at RT were performed to stop the reaction, and flow cytometry analysis was carried out. Positive controls were simultaneously prepared by an additional treatment with 10 IU DNase I for 10 min at 15
• C-25
• C before the elongation reaction. Monitored parameters were FS log, SS log, and FL1 (FITC). TUNEL positive spermatozoa were considered DNA damaged.
Statistical analysis
Results are shown as mean ± SEM of the number of assays indicated in each case. Statistical analyses were performed to determine whether there were significant differences between samples. Data distribution was analyzed by the Kolmogorov-Smirnov normality test. Differences between experimental groups were analyzed by means of ANOVA, and post hoc comparisons were made using the StudentNewman-Keuls multiple comparisons test. A P value of < 0.05 was considered statistically significant. In order to simplify the interpretation of the statistical results, P values less or equal to 0.05 are represented together by the same symbol in the figures. The GraphPad InStat software (3.01; San Diego, CA, USA) was used for CTC staining and tyrosine phosphorylation blots. Flow cytometry data, expressed as percentages, were analyzed by the Chi-square test (SPSS Software version 14.0, SPSS, Inc., Chicago, IL, USA).
Results
Identification of JNK and p38 MAPKs in ram spermatozoa
Indirect immunofluorescence assays evidenced the presence of JNK in ejaculated ram spermatozoa with a high-intensity labeling at the acrosome of 83.5 ± 1.5% of cells ( Figure 1A and B) . Furthermore, 58.0 ± 6.4% of cells also showed a reactive spot at the neck. The results obtained for p38 kinase also revealed an intense signal at the acrosome of 82.2 ± 5.3% spermatozoa ( Figure 1C and D) . While labeling at the neck was not evidenced, nearly all spermatozoa presented reactivity for this MAPK at their flagella. In all the experiments, the omission of the primary or the secondary antibodies resulted in no fluorescent signal, which rules out the possibility of nonspecific binding (data not shown). The presence of both MAPKs was also confirmed by western blot analysis of sperm lysates ( Figure 1E and F) . JNK identification revealed a main protein band of 54 kDa corresponding with the predicted molecular weight for JNK/SAPK1a. In the case of the p38 MAPK, a specific band of 38 kDa was evidenced. In both western blot assays, we simultaneously included a positive antigen control (EGF-stimulated A431 cell lysate), which showed reactivity with both anti-JNK and -p38 antibodies at the same molecular weight as the sperm protein bands described above. Other controls omitting either the primary or the secondary antibodies were carried out, and the results showed no signal at all (data not shown).
The activation state of JNK and p38 is reduced by specific inhibitors and seminal plasma proteins
Once the presence of JNK and p38 MAPKs was evidenced in ram spermatozoa, we analyzed their phosphorylation levels and the effect of the addition of specific JNK (JNKi) or p38 (p38i) inhibitors before incubation in capacitating conditions. We found that the phosphorylation of JNK remained largely unchanged after 3 h of incubation in both control and EGF-containing samples (Figure 2A) . A band of approximately 50 kDa was detected, coincident with that in the EGF-stimulated A431 cell used as a positive control. The addition of 100 μM (established as the most effective concentration) of the cell-permeable and selective JNKi resulted in a significant reduction of the p-JNK signal intensity. In order to verify whether the reported protective effect of SPPs on ram sperm capacitation [21] and apoptosis [20] is associated with JNK and p38 MAPK pathways, we added SPP either alone or together with the inhibitor to the EGF-containing samples before incubation in capacitating conditions. SPPs were able to reduce the JNK activation estate, either alone or together with JNKi. An inhibition of 65.3 ± 11.6% was found in the presence of SPP alone relative to EGF-capacitated samples (Figure 2A and B) .
Similarly, the p38 MAPK is activated through phosphorylation on both threonine and tyrosine residues at the Thr-X-Tyr dual phosphorylation motif, where X is glycine. The used antibody detects the isoform p38α, when it is phosphorylated on Thr180/Tyr182. The results obtained showed that the p38 MAPK was already phosphorylated (activated, evidenced by a band of 38 kDa) in fresh ram spermatozoa (0 h) and after 3 h of incubation in control conditions. The addition of either p38i or SPP prevented p38 activation with a reduction in p38 phosphorylation signaling of 55.57 ± 3.7% with p38i and 56.5 ± 6.5% with SPP, relative to the EGF-induced capacitation ( Figure 2C and D) .
Inhibition of JNK and p38 did not affect the capacitation changes induced by cAMP but reduced the EGF-induced capacitation in a dose-dependent manner
To investigate the involvement of JNK and p38 MAPKs in ram sperm capacitation, the effect of both inhibitors was simultaneously analyzed in control samples (BSA-TALP medium) and two treatment groups with either cAMP-elevating agents (cocktail) or 100 nM EGF, both media having been proved to strongly stimulate capacitation in sheep [12, 19, 46] .
The results obtained showed that JNKi reduced the EGF-induced capacitation, while no effect was found in the control or highcAMP samples. A significant increase in the percentage of noncapacitated sperm pattern (CTC staining) was found in the EGF samples ( Figure 3A ) after 3 h of incubation with 50, 70, or 100 μM JNKi (from 32.2 ± 4.8% up to 48.0 ± 2.7%, 47.3 ± 3.7%, and 47.7 ± 8.1%, respectively). A concomitant decrease in the percentage of capacitated pattern was also found (from 45.7 ± 4.9% to 33.3 ± 1.4%, 28.7 ± 2.3%, and 32.0 ± 6.5%, respectively) although these changes were not statistically significant. Phosphotyrosine protein densitometry analyses ( Figure 3B and C) also revealed a reduction in the total signal intensity associated with capacitation; an inhibition of 48.1 ± 10.4% (70 μM JNKi) and 39.2 ± 8.5% (100 μM JNKi, P < 0.05) was found relative to EGF-containing samples without JNKi.
Similarly, the addition of the specific p38i to the EGF-containing samples accounted for a significant reduction in the proportion of capacitated spermatozoa from 57.0 ± 2.5% without inhibitor down to 43.6 ± 7.5% (P < 0.05), 36.0 ± 7.0% (P < 0.01), and 27.3 ± 2.1% (P < 0.001) with 50, 70, and 100 μM p38i, respectively. This dose-dependent decrease in the capacitated sperm pattern rate was matched with an increase in the noncapacitated population from 13.0 ± 3.6 (EGF control) up to 35.6 ± 5.8% (P < 0.01), 38.3 ± 4.9% (P < 0.001), and 48.6 ± 3.76% (P < 0.001) with 50, 70, and 100 μM p38i, respectively. No changes in the CTC pattern were found when the p38i was added to the control or high-cAMPcontaining samples ( Figure 3D ). Phosphotyrosine analysis corroborated these results ( Figure 3E and F) and showed a significant inhibition in the total signal intensity in the presence of 100 μM p38i (46.7 ± 7.4%) relative to the control of EGF-induced capacitation.
Inhibition of JNK and p38 prevents the apoptosis triggering induced by EGF
The evaluation of sperm viability (plasma membrane integrity) by flow cytometry showed that the proportion of membrane-intact spermatozoa was not significantly changed by either the different capacitation medium or the addition of specific inhibitors, ranging from 29.7 ± 4.8% to 35.2 ± 5.5% in the set of experiments with the JNKi ( Figure 4A ) and from 23.9 ± 7.0 to 30.4 ± 4.5% with the p38i ( Figure 4E) . However, the addition of 100 μM of each inhibitor to the EGFcontaining samples resulted in a lower (P < 0.001) sperm rate with inverted PS (32.8 ± 6.6% with JNKi or 30.2 ± 2.9% with p38i) compared to EGF-stimulated samples with no inhibitors (50.3 ± 7.2% and 48.2 ± 5.3, respectively; Figure 4B and F). No significant effect was found with any of the assayed doses of both inhibitors when capacitation was achieved in high-cAMP-containing samples.
A very similar effect was found on the activation of effector caspases (caspase-3 and -7). The sperm proportion with active -3 and -7 caspases significantly decreased (P < 0.001) in the EGFcapacitated sample in the presence of either JNKi (from 48.1 ±
Figure 2. Activation of JNK (phospho-JNK) (A) and p38 (phospho-p38) (C) kinases evaluated by western blotting analysis and quantified by densitometry (B, D).
The used anti-phospho-JNK antibody recognizes JNK when phosphorylated at Thr183/Tyr185 and Thr221/Tyr223 as well as the activation of p38 MAPK through phosphorylation on both threonine and tyrosine residues at the Thr-X-Tyr dual phosphorylation motif, where X is Gly for p38. Mean values ± SEM (n = 6). Actin as a loading control is shown in the lower panels (A, C). Significant differences relative to the EGF-capacitated samples at 3 h ( * ).
9.4% to 34.6 ± 12.6% and to 26.1 ± 6.8%, with 70 and 100 μM, respectively) or p38i (from 51.9 ± 10.2% to 42.2 ± 8.6% and to 39.9 ± 8.7%, with 70 and 100 μM, respectively), (Figure 4C and G) . Again, no significant change was found in the high-cAMP-containing samples.
Incubation in capacitating conditions accounted for an increase in the TUNEL-positive (damaged DNA) sperm rate in both highcAMP and EGF-containing samples, when compared to their controls at 3 h (P < 0.05). The addition of 100 μM JNKi to EGFcontaining samples resulted in a lower (P < 0.001) proportion of DNA-damaged sperm (from 17.4 ± 3.8% in the EGF control at 3 h to 10.7 ± 1.9%). Likewise, the addition of p38i accounted for a reduction (P < 0.001) in the sperm proportion with damaged DNA from 20.6 ± 2.9 to 13.8 ± 2.9% and to 8.8 ± 1.7%, with 70 and 100 μM, respectively) ( Figure 4D and H) .
The specific inhibition of JNK and p38 and the addition of seminal plasma proteins prevent the capacitation-related changes induced by EGF Once proved that the inhibition of both MAPKs reduces the apoptotic-like changes induced by EGF, we assessed the effect of the addition of SPP either alone or together with each inhibitor to the EGF-containing samples before incubation in capacitating conditions. A higher proportion of noncapacitated sperm was found ( Figure 5A ) after the addition of JNKi (33.7 ± 4.1% vs. 15.7 ± 2.5% in the control group, P < 0.001). This increase was even higher when SPPs were added (60.7 ± 1.1% with SPP or 60.6 ± 5.6% in samples with SPP + JNKi, P < 0.001). These results were consistent with a significant decrease (P < 0.001) in the percentage of capacitated sperm, which was 57.2 ± 2.2%, 44.2 ± 2.3%, 21.7 ± 2.0%, and 23.7 ± 3.8% in control, with JNKi, with SPP, and with SPP+ JNKi, respectively. The results of the CTC assays were confirmed by western blotting analyses that revealed a reduction in the total protein tyrosine phosphorylation signal of 37.6 ± 3.3% (JNKi), 50.5 ± 8.7% (SPP), and 52.8 ± 6.8% (SPP+JNKi) compared to the control sample at 3 h (P < 0.01, Figure 5B and C).
These results are in line with experiments carried out with the p38i and SPP. The addition of SPP alone or together with p38i before capacitation resulted in a strong inhibition of the achievement of the capacitated status ( Figure 5D ), increasing (P < 0.001) the noncapacitated subpopulation from 21.0 ± 5.7% (EGF-containing samples at 3 h) to 68.0 ± 2.0% (with SPP) and 68.7 ± 1.5% (with SPP + p38i). Likewise, densitometry quantification of the phosphotyrosine immunoblotting signal also revealed an inhibition (P < 0.001, Figure  5E and F) of the EGF-induced total phosphorylation signal by p38i (27.4 ± 7.8%), SPP (32.3 ± 8.1%), or SPP + p38i (45.9 ± 5.1%).
Seminal plasma proteins prevent apoptosis alterations induced by EGF
We next asked whether SPPs were able to prevent the apoptosis triggering induced by EGF in a similar manner of JNKi and p38i. As shown in Figure 6 , SPPs were more effective preventing the apoptotic alterations than both inhibitors. The addition of SPPs before incubation accounted for a higher (P < 0.001) proportion of intact-plasma membrane (viable) spermatozoa, which increased from 24.9 ± 2.1% in the EGF-containing samples up to 53.2 ± 4.0% with SPP or 53.2 ± 2.3% with SPP + JNKi ( Figure 6A ). Similar results were found after the addition of p38i, with an increase in viability from 30.8 ± Figure 3 . Effect of increasing doses of the JNK (JNKi, SP600125) or p38 (p38i, SB203580) inhibitors on the capacitation state of ram spermatozoa evaluated by CTC staining (A, D) in control (n = 8), high-cAMP (n = 6) or EGF (n = 6) containing samples after 3 h of incubation in capacitating conditions. Significant differences relative to control incubated for 3 h in capacitating basal medium (•) and EGF-capacitated samples at 3 h ( * ). Phosphotyrosine proteins were analyzed by western blotting (B, E) and quantified by densitometry, n = 4 (C, F). In the lower panels (B and E), actin as a loading control is shown. Bars represent mean values ± SEM of the total signal intensity ratio to actin of the number of assays indicated in each case. Significant differences relative to control at 3 h (•) and EGF-capacitated samples at 3 h ( * ).
7.5% up to 57.4 ± 0.9% with SPP or 49.4 ± 4.1% with SPP + p38i ( Figure 6E ).
Seminal plasma proteins were also able to abrogate PS translocation in both experimental sets. Capacitation with EGF resulted in 48.7 ± 5.6% ( Figure 6B ) or 50.2 ± 2.9% ( Figure 6F ) spermatozoa with inverted PS, and this proportion significantly decreased (P < 0.001) to 35.5 ± 9.9% and 37.0 ± 7.5% with the specific JNKi or p38i, respectively. Even more, the inverted-PS sperm rate broke down to 27.5 ± 4.5% and 27.9 ± 4.3% (P < 0.001) when capacitation was carried out in the presence of SPPs. The addition of SPPs together with either JNKi or p38i resulted in a similar reduced (P < 0.001) sperm proportion with inverted PS (26.2 ± 3.9 and 29.6 ± 6.8, respectively, Figure 6B and F) . This protective effect exerted by SPPs was also confirmed by assessing the activation state of caspase-3 and -7 ( Figure 6C and G) . Thus, the addition of SPPs before capacitation accounted for a strong Mean values ± SEM (n = 5). Significant differences relative to the EGF-capacitated samples at 3 h ( * ). Tyrosine phosphorylation signal evaluated by western blotting in the same conditions as described above (B, E) and quantified by densitometry (C, F). In the lower panels (B and E), actin as a loading control is shown. Bars represent mean values ± SEM (n = 4) of the total intensity signal ratio to actin. Significant differences relative to the EGF-capacitated samples at 3 h with neither inhibitors nor SPP ( * ). inhibition in the triggering of apoptosis, decreasing (P < 0.001) the sperm percentage with active caspases from 55.6 ± 3.6% and 52.6 ± 13.5% in the controls of each set of experiments to 23.9 ± 3.0% and 29.1 ± 7.9%, respectively. The incubation with the specific MAPK inhibitors also implied a reduced (P < 0.001) sperm proportion with active caspase-3 and -7 (38.4 ± 6.4% with JNKi and 36.7 ± 8.3% with p38i). The effect of the addition of SPPs together with either JNKi or p38i did not differ from that of SPP alone ( Figure 6C and G).
To further clarify the mechanism of the SPP protective effect, we performed TUNEL analyses, and we found that the most relevant change was the proportion of spermatozoa with damaged DNA associated to the addition of SPPs. While we found 21.0 ± 9.7% ( Figure 6D ) and 29.4 ± 8.2% ( Figure 6H ) of TUNEL positive spermatozoa in the control samples, the presence of SPPs during incubation resulted in around three times lower values, either with SPP alone (5.3 ± 3.3% and 8.6 ± 1.3%, respectively) (P < 0.001) or in combination with JNKi (10.6 ± 3.6%) or p38i (5.6 ± 1.4%) (P < 0.001, Figure 6D and H).
Discussion
Sperm response to extracellular stimuli is mediated by cell signaling cascades of intracellular kinases and phosphatases [47] . The results of this study show for the first time the presence of two MAPKs, JNK and p38, in ram spermatozoa and their activation during in vitro capacitation induced by EGF. Both kinases are located at the acrosome of most spermatozoa, more than half also showed a signaling spot of JNK at the neck, and nearly all spermatozoa presented p38 labeling at the flagella. These labeling distinctions suggest differences in the role of each kinase in sperm physiology, which is consistent with the pivotal role that cell compartmentalization plays in MAPKs signal transduction. Thus, MAPKs can be arranged in scaffold proteins that provide the right environment for them to interact with their specific activator and substrates [48] .
The presence of both MAPKs in ram spermatozoa was confirmed by western blot analysis that identified JNK as a main protein band of 54 kDa, corresponding with the predicted molecular weight for isoform JNK1a. Other bands also recognized by the antibody may correspond to other isoforms, JNK1b (54 kDa) and JNK1c (45 kDa), according to previous results that described three isoforms of JNK with a size between 40 and 50 kDa in mammalian testis [7, [49] [50] [51] . In the case of p38 MAPK, a specific band of 38 kDa was evidenced. These results were confirmed including suitable positive controls that showed reactivity with both anti-JNK and p38 antibodies at the same molecular weight as the sperm protein bands.
To verify the involvement of these pathways in ram sperm physiology as two signal transduction mechanisms that contribute to the modulation of capacitation and apoptosis, we tested the effect of specific JNK and p38 inhibitors on capacitation with EGF. The inhibition of each enzyme resulted in the inhibition of capacitation, with a decrease in both the percentage of capacitated-sperm pattern and protein tyrosine phosphorylation. The concentration used of each specific inhibitor (JNKi and p38i, 100 μM) is within the range of those used with mouse spermatogonial stem cells [52] as well as with other cell types [33] [34] [35] [36] . Likewise, JNKi or p38i was also able to inhibit the apoptosis triggering, as was evidenced by the reduced levels of apoptotic markers (PS translocation, activation of caspases, and DNA fragmentation). This is consistent with the fact that the most recognized biological response triggered by JNK activation is apoptosis (for reviews, see [53, 54] ). In mammalian cells, most stimuli that activate JNK also activate p38 [55, 56] , which is strongly activated by environmental stresses and inflammatory cytokines [57] . The reported data suggest a correlation between the activation of the p38 pathway and apoptosis, functioning both upstream and downstream of caspases in the apoptotic response that seems to be cell type and stimulus dependent [56] . Our results confirm that both MAPKs are involved in the apoptosis in ram spermatozoa.
Next, we attempted to investigate whether there could be a crosstalk between these two MAPK signaling cascades and the canonical cAMP/PKA pathway traditionally described as leading ram sperm capacitation [19, 29] . The cAMP role in regulating cell proliferation by interacting with the MAPK pathway through the ERK MAPK module has been studied as a model of crosstalk between proteins of different signaling pathways [58] . To try to determine whether this crosstalk between cAMP and JNK or p38 MAPK could also occur during in vitro ram sperm capacitation induced by either a cAMP-elevating cocktail or EGF, we studied the effect of specific inhibitors of each enzyme. While both inhibitors affected capacitationand apoptosis-related changes in the EGF-capacitated samples, no significant effect was detected with high cAMP. These results suggest a link between the EGF-stimulated and the JNK or p38 MAPK pathways, while a direct connection between the PKA stimulation by cAMP and the JNK or p38 pathways should be ruled out. These data indicate that the EGF-induced capacitation-related changes and the apoptotic process share, at least, a part of their signaling pathways. This connection between capacitation and apoptosis would ensure that those spermatozoa that have been capacitated would either bind to the oocyte or die without inducing inflammation. An association between capacitation and apoptosis, by their common dependence on the continued generation of reactive oxygen species, has already been proposed [59] .
Finally, to provide a new approach to the mechanism that allows SPPs to protect spermatozoa and to study the molecular engineering that is behind this protective and decapacitating effect, we included SPP alone or with each inhibitor in the EGF-containing samples. The results showed that SPPs prevented the capacitation-related changes induced by EGF, with a strong increase in the percentage of noncapacitated sperm pattern and a significant inhibition of protein tyrosine phosphorylation. Similar decapacitating effect has been reported for the SP protein SPINKL in mouse spermatozoa [60, 61] , and for two specific SPP fractions (RSVP14 and RSVP20) in ram spermatozoa [21] . Moreover, the addition of SPPs during incubation in EGF-capacitating conditions resulted in a decrease in the apoptosisrelated markers. These results are in accordance with those from other studies that reported the protective effect of SPPs on DNA damage during human sperm preparation [62] , sperm cryopreservation, and other biotechnologies [63] , and corroborate our previous results [20, 30] .
Interestingly, the activation of both JNK and p38 MAPK by double phosphorylation was inhibited not only by their specific inhibitors, as expected, but also by SPPs. The addition of SPPs before in vitro capacitation accounted for a lower JNK and p38 phosphorylation, which suggests that SPPs could exert, at least partially, their protective [20, 30, 64] and decapacitating [21] effect through JNK and/or p38 inhibition. It is worth noting that both phosphorylated (active) forms of JNK and p38 kinases are already present in the fresh ram sperm samples selected by the swim-up procedure (0 h). This may be due to the high heterogeneity of ram semen, and it is indicative of different sperm physiological states from immature up to dead cells [27, [65] [66] [67] [68] [69] . Furthermore, the fact that both kinases are not significantly activated after 3 h of incubation with EGF must Figure 7 . Schematic diagram of the signaling pathways involved in the regulation of ram sperm capacitation and apoptosis. The intracellular increased levels of calcium and bicarbonate that occur in spermatozoa during capacitation (1) induce the activation of the soluble adenylyl cyclase enzyme (sAC), resulting in the generation of cAMP (2) . The high levels of cAMP activate the serine/threonine kinase A (PKA) that, once activated, produces the tyrosine phosphorylation of different target proteins (3) , which is at least partially involved in ram sperm capacitation [19, 29] . The MAPK ERK 1/2 was shown [12] to be involved in ram sperm capacitation (4) through a sequential kinase cascade (Ras-Raf-MEK-ERK) in response to the association of the EGF to its cell-surface receptor EGF-R (5), thus leading to the activation of tyrosine kinases and other capacitation-related events. Both the EGF/EGF-R binding and different extracellular stress stimuli, including UV radiation, heath shock, osmotic stress, and cytokines (6) may activate downstream signaling pathways of other MAPK modules, such as JNK and p38 MAPKs through a parallel mechanism of consecutive activation of several specific kinases [7] . The specific inhibition of JNK (7) or p38 (8) results in reduced capacitated-sperm pattern and tyrosine phosphorylated proteins when EGF was the inducer of capacitation, while no significant changes were found in high-cAMP-containing samples. Both inhibitions caused decreased values of the evaluated apoptotic markers, including membrane integrity (9), PS externalization (10), DNA fragmentation (11), and caspases activation (12) . Incubation with SPPs was able to prevent both the EGF-induced capacitation and the apoptosis alterations, at least partially by inhibiting the phosphorylation (activation) of JNK and p38 MAPKs (13, 14) , in agreement with the reported protective [20, 30] and decapacitating [21] effect of SPPs on ram spermatozoa. The suggested crosstalk between capacitation and apoptosis might be explained as a dual mechanism by which a spermatozoon is able to fulfill its mission: undergoing capacitation to acquire the ability to fertilize the oocyte (fecundation) or entering into a process of a non-inflammatory cell death (apoptosis).
be highlighted. These enzymes are activated in response to environmental stress by several stimuli including, among others, oxidative stress and heat and osmotic shock [1, 55, 56, 70] . Then, the incubation of 3 h at 39
• C might be sufficient to induce their activation, particularly JNK, which reached the same level in control and EGFcontaining samples. In the case of p38 kinase, the incubation with EFG resulted in a higher activation state, although the difference was not statistically different. These data would indicate that those double phosphorylations of JNK and p38 MAPK might take place partly by "spontaneous" capacitation during incubation, regardless of the presence of EGF, which would be in agreement with recent results showing that the treatment with an EGF domain did not increase the activation of JNK [71] . Furthermore, it must be taken into account that the removal of SP by the swim-up process would result in a particularly sensitive sperm sample. Thus, different studies have shown that when mammalian spermatozoa are devoid of SP, most decapacitating factors loosely associated to the sperm surface are also removed [72] [73] [74] [75] [76] [77] [78] . These factors prevent changes in the membrane needed for capacitation and/or the transduction signals of capacitation to other parts of the cell [78] [79] [80] . Therefore, their removing would avoid the SP protective effect, increasing the sperm sensitivity. The fact that both inhibitors reduce capacitation and apoptosis-related changes induced by EGF not by cAMP suggests a specific link between these MAPK and the EGF-induced capacitation. The remarkable point of the results obtained in this study is that SPPs are able to prevent the capacitation-and apoptosis-related changes interfering with JNK and p38 pathways.
In conclusion, the current results confirm the involvement of both JNK and p38 MAPKs as new modules that take part in the EGF cellular signal transduction in ram spermatozoa. The specific inhibition of JNK or p38 in EGF-containing samples accounted for a decrease in the capacitation-related events and apoptotic marker levels. Similar effects were found when SPPs were added to EGF-containing samples. Our findings support the hypothesis that capacitation and apoptosis could share common molecular signaling pathways and show, for the first time, that JNK and p38 MAPKs as well as SPPs may be involved in both processes. Likewise, the data corroborate that SPPs are able to modulate these two events. Based on these results, together with those from previous studies, we propose the model shown in Figure 7 for the molecular mechanism of EGF, PKA, JNK, and p38 MAPK signaling cascades involved in ram sperm capacitation and apoptosis.
In addition, the data show that SPPs are able to protect sperm not only acting at the plasma level as reported previously, but also by interfering with both MAPK pathways. Given that the sequences of SPP identified as sperm protectors in ram share a high homology with those of other mammalian species [81, 82] , SPP could be useful for the development of strategies for improving semen-based reproductive technologies in mammalian species. Further investigation into the protective effect and decapacitating mechanisms of SPP at a molecular level throughout the signaling cascades involved in sperm capacitation and apoptosis triggering appears to be essential to achieve a better understanding of sperm physiology.
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